Nils Bergenhem
Directeur Technique/Scientifique/R&D chez Egenix, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| M. Young | M | - |
Egenix, Inc.
 Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 10 ans |
| Lionel Goldfrank | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 10 ans |
| John T. Reid | M | 84 |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 12 ans |
| Rainer Fuchs | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 12 ans |
| Jack Daiss | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Arshad Siddiqui | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 11 ans |
| Emanuel F. Petricoin | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 10 ans |
| William T. Nolan | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 9 ans |
| Matthew Fury | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Adrian Schwarzer | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Stephan Vagner | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Donald C. Fresne | M | 96 |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Gerard Karsenty | M | - |
Escoublac, Inc.
 Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA. | 5 ans |
| Barbara Wood | F | 62 | 9 ans | |
| Dominic Piscitelli | M | 50 | 10 ans | |
| Linda E. Amper | M | 67 | - | |
| Mark P. Richmond | M | 92 | 7 ans | |
| Arthur M. Bruskin | M | - | - | |
| Nicole Onetto | M | 71 | 3 ans | |
| Robert L. Simon | M | 79 | - | |
| David Niemiec | M | 74 | 9 ans | |
| Kirk A. Christoffersen | M | 56 | 2 ans | |
| David Laskow-Pooley | M | 70 | 2 ans | |
| Neil Gibson | M | 67 | 6 ans | |
| Karsten Witt | M | 68 | 9 ans | |
| Anthony Brown | M | - | - | |
| Andy Crew | M | 59 | 11 ans | |
| Karrar Khan | M | - | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 28 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Nils Bergenhem
- Réseau Personnel
